“The Specialist” signs five international agreements to enhance medical innovation during the Saudi -American Investment Forum

Dr. Majid bin Ibrahim Al -Fayyad, CEO of King Faisal Specialist Hospital and Research Center, valued the unlimited support from the Custodian of the Two Holy Mosques King Salman bin Abdulaziz Al Saud, and His Highness the Crown Prince Muhammad bin Salman bin Abdulaziz for the health sector march in the Kingdom, stressing that this support enabled the “specialized” to turn into a leading global health institution. Health for the next generation: Saudi-American cooperation in biotechnology and digital health, which was held within the work of the Saudi-American Investment Forum 2025 at the King Abdulaziz International Convention Center in Riyadh.

During the session, Dr. Al -Fayyad reviewed the features of the comprehensive transformation witnessed by the hospital, which is to enhance clinical distinction, expand the fields of research and education, and achieve financial sustainability, in line with the targets of Saudi Vision 2030. He also stressed the importance of investing in advanced medical technology to improve spending efficiency and ensure high -quality treatment results.

Dr. Al -Fayyad emphasized that the hospital adopts advanced therapeutic techniques such as Treatment with TT cells and robotic surgeries, and provides advanced specialized services in organ transplantation and personal medicine, which contributes to reducing the need for travel for treatment abroad, and enhances the Kingdom’s position as a regional health care center.

The occasion witnessed the signing of five international cooperation agreements, represented in a memorandum of understanding with the Cleveland Clinic Foundation in the field of autism and neuroscience, a tripartite agreement with Al -Qaddiya Investment Company and the Cleveland Clinic Foundation in the field of sports medicine and performance, a memorandum of cooperation with the Jeremfrey Company for the Development of Advanced Medical Laborators, and an agreement with the Medteronic company to secure the requirements of the heart center and establish a new catheter center, in addition to To a memorandum of understanding with Amante Bayu, in cooperation with the King Abdullah International Medical Research Center and the Ministry of Investment to establish an advanced national platform for biotechnology in the field of immunodeficiency for cancer and infectious diseases.

These posts and agreements are an affirmation of the “specialized” commitment to enhancing innovation and international cooperation, and establishing strategic partnerships that enhance the Kingdom’s role in localizing technology and developing health care.